MicroRNA-382 Promotes M2-Like Macrophage via the SIRP-α/STAT3 Signaling Pathway in Aristolochic Acid-Induced Renal

Xiaoyan Wang1,2,3, Ping Jia1,2,3,4, Ting Ren1,2,3

  • 1Department of Nephrology, Zhongshan Hospital, Fudan University, Shanghai, China.

Insights

MicroRNA-382 drives kidney fibrosis by promoting M2 macrophage activation in aristolochic acid nephropathy. Inhibiting miR-382 or STAT3 may offer therapeutic strategies for this kidney disease.

Area of Science:

  • Nephrology
  • Immunology
  • Molecular Biology

Background:

  • Aristolochic acid nephropathy (AAN) is linked to kidney fibrosis.
  • The role of microRNA-382 (miR-382) in macrophage activation during AAN is unknown.

Purpose of the Study:

  • Investigate miR-382's role in macrophage activation and kidney fibrosis in AAN.
  • Determine if miR-382 is a potential therapeutic target for AAN.

Main Methods:

  • Cell sorting to identify miR-382 in renal macrophages.
  • miR-382 knockout mice and bone marrow-derived macrophages (BMDM) subjected to aristolochic acid (AA).
  • Adoptive transfer, dual-luciferase assay, STAT3 inhibition, and coculture experiments.

Main Results:

  • miR-382 is enriched in renal macrophages in AAN and promotes M2 polarization.
  • miR-382 knockout or depletion suppresses M2 activation and kidney fibrosis.
  • miR-382 targets SIRP-α, activating STAT3 and promoting macrophage-tubular cell crosstalk.
  • STAT3 inhibition reduces fibrosis and M2 polarization.

Conclusions:

  • miR-382 is a key mediator of M2-like macrophage polarization in AAN.
  • miR-382 and STAT3 signaling are critical in AA-induced kidney fibrosis.
  • miR-382 represents a promising therapeutic target for kidney fibrosis.